miR-10a-5p Promotes Chondrocyte Apoptosis in Osteoarthritis by Targeting HOXA1

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoarthritis (OA) is a degenerative joint disease impacting articular cartilage and causing inflammation.
• MicroRNAs (miRNAs) play a crucial role in regulating chondrocyte apoptosis, a key factor in OA pathogenesis.
• miR-10a-5p is found to be significantly upregulated in osteoarthritic cartilage, but its specific role was previously unknown.

Purpose of the Study:

• To investigate the role of miR-10a-5p in promoting osteoarthritis.
• To elucidate the molecular mechanism by which miR-10a-5p influences chondrocyte apoptosis and OA progression.

Main Methods:

• In vitro studies using chondrocytes treated with interleukin-1β to assess miR-10a-5p expression and apoptosis.
• Luciferase activity assays to identify the target gene of miR-10a-5p.
• In vivo studies using a mouse model of osteoarthritis (anterior cruciate ligament transection) to evaluate the effects of miR-10a-5p modulation.
• Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay to quantify apoptosis.

Main Results:

• Interleukin-1β treatment increased miR-10a-5p expression in chondrocytes, and inhibiting miR-10a-5p reduced interleukin-1β-induced apoptosis.
• miR-10a-5p was found to directly target the 3' UTR of the homeobox gene HOXA1, inhibiting its expression.
• In vivo, antagomiR-10a-5p improved cartilage in OA mice, while agomiR-10a-5p worsened it.
• miR-10a-5p knockdown in OA mice reduced apoptosis and increased HOXA1 expression.

Conclusions:

• miR-10a-5p promotes osteoarthritis progression by inducing chondrocyte apoptosis through the inhibition of HOXA1.
• Modulating miR-10a-5p levels and targeting the miR-10a-5p/HOXA1 pathway represent potential therapeutic strategies for osteoarthritis.